Electro Regenerative Medecine was born out of a deep desire to help people suffering with chronic health issues. Creator and owner David Petroviak had an experience with a prototype device built according to Nikola Tesla’s long expired patents and realized the technology had real healing power for a number of chronic issues. It was then than development on a new device began and after some time of development and improvements the ERT was born.
People who used the ERT noticed drastic changes in many different issues and the ERT was launched. Early on new stories began to come in and expanded the already long list of conditions that could be helped by ERT. To this day we still get calls from our family of doctors with new stories of improvement in an ever growing list of conditions.
ERT provides a streamlined, turn-key solution for doctors to implement into their practices. We make it far easier to learn, implement and profit from a therapy that truly works and one where the patient will notice an immediate difference.
ERT began in 2010 with a mission and vision to provide a better, simpler, yet more effective therapy that makes a real difference for patients. Since then we have helped over 150 clinics (and growing) throughout the country to better serve their patients and their communities by providing a simple, proven solution for those struggling with chronic health challenges.
ERT “Electro Regenerative Therapy” is a cutting edge, real world, incredibly effective therapy for a long list of issues experienced by a great majority of the population. What makes ERT different is that other than being based on the world renowned PEMF technology, the ERT is the best of the PEMF based devices but built in a very different way. Not only do we adhere closely to the original design info created by Nikola Tesla but we have included a number of specific healing frequencies that are interwoven into the pulse. These frequencies do a great deal when paired with a properly formed pulse. When we talk about pulse we are well aware that nearly every other device that uses PEMF technology in the moderate and higher power ranges is very uncomfortable for most people.
At ERT we sought to create a device that would create real and rapid improvement without the pinch or painful experience nearly all other devices create. We often hear that our therapy is very pleasant and feels like a nice massage. People who have used other PEMF based devices are often very shocked at the difference. Our doctors commonly report that patients with various conditions report massive and immediate improvement rather than the idea of dozens of sessions to show any change as is often the case with other PEMF based devices. We pride our selves on this and the relationships with our wonderful family of doctors.
Dr. Marc Funderlich the regenerative and longevity medicine space for 6 years. Dr. Funderlich is currently working in all verticals of Regenerative Medical Space participating in everything from medical device management to IRB approved research.
He has been teaching continuing medical education since 2018 and has been focused on medical device education. Education topics have included PEMF, Low Level Laser, Hyperbaric Oxygen, Immunology, and Neurology. The Wisconsin Chiropractic Association has him speak on average twice a year at their major conventions as well as for audiences ranging from 50-400 physicians. Many device companies such as Erchonia Corporation and other reach out on a regular basis.
Other fields of interest include his own company; Regenerative Cell Therapy Corporation. Which has been producing and selling umbilical cord derived mesenchymal stromal cells as well as cord and plasma derived exosomes. Our most recent expansion has been into oral peptide and topical stem cell creams, filling in the market gap.
Now at Johns Hopkins, Dr. Funderlich is a part of the future of regenerative and stem cell medicine. Learning laboratory techniques such as the culturing and cloning of stem cells, gene / immune therapy utilization in the form of CRISPR and Cas-9, as well as being educated in legality, public policy, and bringing new biologic drugs to market.
Finally, Dr. Funderlich is engaged in IRB approved regenerative medicine research with Versa Health and the University of California Davis. His goal is to bring new clinically relevant cellular testing and translate the diagnostics into researched cellular therapy protocols.
